Upgrades/Downgrades
Updated: 09-Jun-26 12:05 ET
| Upgrades | |||||
| Company | Ticker | Brokerage Firm | Ratings Change | Price Target | |
| PTC Therapeutics | PTCT | Citigroup | Neutral » Buy | $108 | |
| West Pharm | WST | Barclays | Equal Weight » Overweight | $400 | |
| Toll Brothers | TOL | Keefe Bruyette | Mkt Perform » Outperform | $161 | |
| PAR Technology | PAR | JP Morgan | Underweight » Neutral | $16 | |
| FuelCell Energy | FCEL | Canaccord Genuity | Hold » Buy | $30 | |
| Brady | BRC | Sidoti | Neutral » Buy | $103 | |
| Arthur J. Gallagher | AJG | UBS | Neutral » Buy | $250 | |
|
|
|||||
| Downgrades | |||||
| Company | Ticker | Brokerage Firm | Ratings Change | Price Target | |
| Lennar | LEN | Keefe Bruyette | Mkt Perform » Underperform | $86 | |
| Ingredion | INGR | Oppenheimer | Outperform » Perform | ||
| Equity Residential | EQR | RBC Capital Mkts | Outperform » Sector Perform | $70 | |
| Prudential | PRU | Argus | Buy » Hold | ||
|
|
|||||
| Coverage Initiated | |||||
| Company | Ticker | Brokerage Firm | Ratings Change | Price Target | |
| Precision BioSciences | DTIL | Oppenheimer | Outperform | $20 | |
| Perimeter Solutions | PRM | CJS Securities | Market Outperform | $48 | |
| Brookfield Business Corporation | BBUC | TD Cowen | Hold | $34 | |
| WPP plc | WPP | Berenberg | Buy | ||
| Park Aerospace | PKE | Citizens | Mkt Outperform | $42 | |
| Magnite | MGNI | BTIG Research | Buy | $20 | |
| LSI Industries | LYTS | Oppenheimer | Outperform | $30 | |
| Grand Canyon Education | LOPE | Truist | Buy | $200 | |
| Gold.com | GOLD | Canaccord Genuity | Buy | $70 | |
| FrontView REIT | FVR | Raymond James | Strong Buy | $22 | |
| Enliven Therapeutics | ELVN | Stifel | Buy | $60 | |
| Cerebras Systems | CBRS | Craig Hallum | Buy | $325 | |
| NioCorp Developments Ltd. | NB | B. Riley Securities | Buy | $12 | |
| WhiteFiber | WYFI | Barclays | Equal Weight | $27 | |
| VEON | VEON | Northland Capital | Outperform | $70 | |
| Kyntra Bio | KYNB | Rodman & Renshaw | Buy | $30 | |
|
|
|||||
| Coverage Resumed | |||||
| Company | Ticker | Brokerage Firm | Ratings Change | Price Target | |
| Jazz Pharma | JAZZ | Truist | Buy | $256 | |
| Zymeworks | ZYME | Truist | Buy | $28 | |
| Ralliant Corporation | RAL | Evercore ISI | Outperform | $80 | |
|
|
|||||
| (a) Brokerage firm initiating coverage participated in underwriting the recent IPO. |
| (b) Brokerage firm resumes coverage. |
| (c) Brokerage firm participated in the secondary offering. |
| * This list of reiterations/target changes is not comprehensive. |